Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
about
Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.Neuropsychiatric symptoms in Alzheimer's disease: Associations with caregiver burden and treatment outcomes.Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
P2860
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@ast
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@en
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@nl
type
label
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@ast
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@en
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@nl
prefLabel
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@ast
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@en
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@nl
P2860
P50
P921
P356
P1476
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
@en
P2093
Victor Bloniecki
P2860
P304
P356
10.1159/000363500
P577
2014-05-01T00:00:00Z